Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial

Area of Science:

• Neurology
• Cardiovascular Medicine
• Interventional Radiology

Background:

• Atherosclerotic disease affecting major intracranial arteries is a significant cause of stroke.
• Patients with symptomatic intracranial stenosis face a high risk of recurrent stroke.
• Existing data on angioplasty and stenting for intracranial stenosis are primarily from case series.

Purpose of the Study:

• To review current data on angioplasty and stenting for severe intracranial stenosis.
• To discuss the rationale for conducting a randomized trial.
• To compare angioplasty and stenting against best medical management for symptomatic intracranial stenosis.

Main Methods:

• Review of existing case series data on angioplasty and stenting for intracranial stenosis.
• Discussion of the need for randomized controlled trials.
• Outline of the proposed design for a randomized trial comparing intervention versus medical management.

Main Results:

• Preliminary studies suggest potential benefits of angioplasty and stenting in reducing stroke risk for severe intracranial stenosis.
• No randomized studies have been completed to date, limiting definitive conclusions.
• Case series data indicate a need for further investigation through rigorous clinical trials.

Conclusions:

• Angioplasty and stenting show promise for treating severe intracranial stenosis.
• A randomized trial is warranted to definitively assess the efficacy of angioplasty and stenting compared to best medical management.
• Further research is crucial to establish optimal treatment strategies for preventing recurrent stroke in this high-risk population.